EFFECT OF HIGH-DOSE APROTININ ON BLOOD-CELL FILTERABILITY IN ASSOCIATION WITH CARDIOPULMONARY BYPASS

被引:11
作者
LIU, B
BELBOUL, A
ALKHAJA, N
RADBERG, G
DERNEVIK, L
ROBERTS, D
WILLIAMOLSSON, G
机构
[1] Thoracic/Cardiovascular Surg. Dept., Sahlgrenska Hospital
关键词
APROTININ; CARDIOPULMONARY BYPASS; RED CELL FILTERABILITY; WHITE CELL FILTERABILITY;
D O I
10.1097/00019501-199202000-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous studies showed that high-dose aprotinin reduces postoperative bleeding in heart surgery and that blood cell rheologic parameters correlate to postoperative bleeding and other complications. Methods: To evaluate the blood cell rheologic effect of high-dose aprotinin in patients undergoing coronary artery bypass graft surgery, we studied 68 patients (34 receiving high-dose aprotinin during the operation) by use of a microfiltration method to assess blood cell trauma during cardiopulmonary bypass. Results: In the control group, red cell filtration rate (RFR, mu-L/s) values were significantly reduced from a preoperative level of 55.8 to a level of 37.2 on day 1 (P < 0.002) and to a level of 44.5 on day 6 (P < 0.05) after surgery. The respective values for white cell filtration rate (WFR, mu-L/s) were 17.0, 8.2 (P < 0.002), and 10.0 (P < 0.005). In the aprotinin group, RFR (mu-L/s) values were reduced, but not as significantly (58.8 preoperative, 48.1 on day 1, P > 0.05, and 50.4 on day 6, P > 0.05). The respective values for WFR (mu-L/s) were 17.5, 15.7 (P > 0.05), and 15.8 (P > 0.05). Conclusions: Blood cell rheologic function, which is known to be an important factor for adequate microcirculation and which when reduced is associated with postoperative morbidity, was shown to be protected by aprotinin in this study.
引用
收藏
页码:129 / 132
页数:4
相关论文
共 19 条
[1]   CUTANEOUS MICROCIRCULATION AND BLOOD RHEOLOGY FOLLOWING CARDIOPULMONARY BYPASS - LASER DOPPLER FLOWMETRIC AND BLOOD-CELL RHEOLOGIC STUDIES [J].
ALKHAJA, N ;
BELBOUL, A ;
BERGMAN, P ;
ROBERTS, D ;
WILLIAMOLSSON, G .
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1988, 22 (02) :149-153
[2]  
ALKHAJA N, 1991, BLOOD USE IN CARDIAC SURGERY, P44
[3]  
BAGGE U, 1975, WHITE BLOOD CELL RHE
[4]  
BIDSTRUP BP, 1989, J THORAC CARDIOV SUR, V97, P364
[5]  
BLAUHUT B, 1991, J THORAC CARDIOV SUR, V101, P958
[6]   COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - EVIDENCE FOR GENERATION OF C3A AND C5A ANAPHYLATOXINS [J].
CHENOWETH, DE ;
COOPER, SW ;
HUGLI, TE ;
STEWART, RW ;
BLACKSTONE, EH ;
KIRKLIN, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (09) :497-503
[7]  
DIETENFASS L, 1985, BLOOD VASCOSITY HYPE
[8]   REDUCTION OF HOMOLOGOUS BLOOD REQUIREMENT IN CARDIAC-SURGERY BY INTRAOPERATIVE APROTININ APPLICATION - CLINICAL-EXPERIENCE IN 152 CARDIAC SURGICAL PATIENTS [J].
DIETRICH, W ;
BARANKAY, A ;
DILTHEY, G ;
HENZE, R ;
NIEKAU, E ;
SEBENING, F ;
RICHTER, JA .
THORACIC AND CARDIOVASCULAR SURGEON, 1989, 37 (02) :92-98
[9]  
EDMUNDS LH, 1991, J THORAC CARDIOV SUR, V101, P1103
[10]   REDUCTION OF BLOOD-TRANSFUSION REQUIREMENT IN OPEN-HEART SURGERY BY ADMINISTRATION OF HIGH-DOSES OF APROTININ - PRELIMINARY-RESULTS [J].
FRAEDRICH, G ;
WEBER, C ;
BERNARD, C ;
HETTWER, A ;
SCHLOSSER, V .
THORACIC AND CARDIOVASCULAR SURGEON, 1989, 37 (02) :89-91